| Income Statement |
| Total Revenue | 370.90M |
|
| Revenues (USD) | 370.90M |
| Cost of Revenue | 130.60M |
| Gross Profit | 240.30M |
| Operating Expenses | 170.59M |
| Research and Development Expense | 19.74M |
| Selling, General and Administrative Expense | 27.71M |
| Operating Income | 69.71M |
| Interest Expense | 58.80M |
| Income Tax Expense | -15.51M |
| Net Income | -225.57M |
| Net Income Common Stock | -225.57M |
| Net Income Common Stock (USD) | -225.57M |
| Consolidated Income | -225.57M |
| Earnings per Basic Share | -0.45 |
| Earnings per Basic Share (USD) | -0.45 |
| Earnings per Diluted Share | -0.45 |
| Earning Before Interest & Taxes (EBIT) | -182.28M |
| Earning Before Interest & Taxes (USD) | -182.28M |
| Weighted Average Shares | 506.20M |
| Weighted Average Shares Diluted | 506.20M |
| Balance Sheet |
| Cash and Equivalents | 160.59M |
| Cash and Equivalents (USD) | 160.59M |
| Trade and Non-Trade Receivables | 576.16M |
| Current Assets | 453.44M |
| Property, Plant & Equipment Net | 3.37B |
| Total Assets | 4.78B |
| Debt Current | 30.22M |
| Total Debt | 2.90B |
| Current Liabilities | 757.05M |
| Debt Non-Current | 2.87B |
| Total Liabilities | 4.27B |
| Accumulated Retained Earnings (Deficit) | -2.01B |
| Shareholders Equity | 515.11M |
| Shareholders Equity (USD) | 515.11M |
| Assets Non-Current | 4.33B |
| Total Debt (USD) | 2.90B |
| Inventory | 182.73M |
| Liabilities Non-Current | 3.51B |
| Trade and Non-Trade Payables | 194.97M |
| Tax Assets | 2.78M |
| Tax Liabilities | 134.75M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 122.47M |
| Net Cash Flow from Financing | 42.89M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 50.80M |
| Capital Expenditure | -87.05M |
| Issuance (Purchase) of Equity Shares | 206.44M |
| Issuance (Repayment) of Debt Securities | -155.82M |
| Net Cash Flow from Investing | -98.64M |
| Net Cash Flow - Investment Acquisitions and Disposals | -11.60M |
| Net Cash Flow from Operations | 106.56M |
| Share Based Compensation | 5.95M |